<VariationArchive VariationID="429301" VariationName="NM_001206744.2(TPO):c.1184_1187dup (p.Ala397fs)" VariationType="Duplication" Accession="VCV000429301" Version="38" RecordType="classified" NumberOfSubmissions="15" NumberOfSubmitters="15" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="421275" VariationID="429301">
      <GeneList>
        <Gene Symbol="TPO" FullName="thyroid peroxidase" GeneID="7173" HGNC_ID="HGNC:12015" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="1374047" stop="1543673" display_start="1374047" display_stop="1543673" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NT_187529.1" start="96661" stop="223095" display_start="96661" display_stop="223095" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="1417232" stop="1546498" display_start="1417232" display_stop="1546498" Strand="+" />
          </Location>
          <OMIM>606765</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001206744.2(TPO):c.1184_1187dup (p.Ala397fs)</Name>
      <CanonicalSPDI>NC_000002.12:1477447:CGGCCG:CGGCCGGCCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="1477447" stop="1477448" display_start="1477447" display_stop="1477448" variantLength="4" positionVCF="1477447" referenceAlleleVCF="A" alternateAlleleVCF="ACGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="1481219" stop="1481220" display_start="1481219" display_stop="1481220" variantLength="4" positionVCF="1481219" referenceAlleleVCF="A" alternateAlleleVCF="ACGGC" />
      </Location>
      <ProteinChange>A397fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000547.5" sequenceAccession="NM_000547" sequenceVersion="5" change="c.1184_1187dupGCCG">
            <Expression>NM_000547.5:c.1184_1187dupGCCG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.1481222_1481225dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.1481222_1481225dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.1477450_1477453dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.1477450_1477453dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011581.1" sequenceAccession="NG_011581" sequenceVersion="1" change="g.68988_68991dup">
            <Expression>NG_011581.1:g.68988_68991dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000547.6" sequenceAccession="NM_000547" sequenceVersion="6" change="c.1184_1187dup">
            <Expression>NM_000547.6:c.1184_1187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000538.3" sequenceAccession="NP_000538" sequenceVersion="3" change="p.Ala397fs">
            <Expression>NP_000538.3:p.Ala397fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001206744.2" sequenceAccession="NM_001206744" sequenceVersion="2" change="c.1184_1187dup" MANESelect="true">
            <Expression>NM_001206744.2:c.1184_1187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001193673.1" sequenceAccession="NP_001193673" sequenceVersion="1" change="p.Ala397fs">
            <Expression>NP_001193673.1:p.Ala397fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001206745.2" sequenceAccession="NM_001206745" sequenceVersion="2" change="c.1184_1187dup">
            <Expression>NM_001206745.2:c.1184_1187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001193674.1" sequenceAccession="NP_001193674" sequenceVersion="1" change="p.Ala397fs">
            <Expression>NP_001193674.1:p.Ala397fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175719.4" sequenceAccession="NM_175719" sequenceVersion="4" change="c.1184_1187dup">
            <Expression>NM_175719.4:c.1184_1187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_783650.1" sequenceAccession="NP_783650" sequenceVersion="1" change="p.Ala397fs">
            <Expression>NP_783650.1:p.Ala397fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175721.3" sequenceAccession="NM_175721" sequenceVersion="3" change="c.1184_1187dup">
            <Expression>NM_175721.3:c.1184_1187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_783652.1" sequenceAccession="NP_783652" sequenceVersion="1" change="p.Ala397fs">
            <Expression>NP_783652.1:p.Ala397fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175722.3" sequenceAccession="NM_175722" sequenceVersion="3" change="c.820-7146_820-7143dup">
            <Expression>NM_175722.3:c.820-7146_820-7143dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000547.5" sequenceAccession="NM_000547" sequenceVersion="5" change="c.1183_1186dup">
            <Expression>NM_000547.5:c.1183_1186dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1511672" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606765.0001" DB="OMIM" />
        <XRef Type="rs" ID="763941231" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expession for allelic variant 606765.0001 based from the sequence reported in Figure 2 of the paper by Abramowicz et al., 1992 (PubMed 1401057).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001206744.2(TPO):c.1184_1187dup (p.Ala397fs) AND not provided" Accession="RCV000494448" Version="24">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-28" SubmissionCount="7">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001206744.2(TPO):c.1184_1187dup (p.Ala397fs) AND Deficiency of iodide peroxidase" Accession="RCV000779280" Version="15">
        <ClassifiedConditionList TraitSetID="1106">
          <ClassifiedCondition DB="MedGen" ID="C1291299">Deficiency of iodide peroxidase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001206744.2(TPO):c.1184_1187dup (p.Ala397fs) AND TPO-related disorder" Accession="RCV003932797" Version="1">
        <ClassifiedConditionList TraitSetID="89190">
          <ClassifiedCondition>TPO-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-28" NumberOfSubmissions="15" NumberOfSubmitters="15" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11061528</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1401057</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15745925</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17468186</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23236987</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23512414</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25564141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27373559</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27617131</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29546359</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30240412</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32765423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36474027</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=TPO</URL>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89190" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71797" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">TPO-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TPO-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="1106" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3903" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2A</ElementValue>
                <XRef Type="MIM" ID="274500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IODIDE PEROXIDASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="274500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A</ElementValue>
                <XRef Type="MIM" ID="274500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">THYROID PEROXIDASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="274500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of iodide peroxidase</ElementValue>
                <XRef ID="Deficiency+of+iodide+peroxidase/8201" DB="Genetic Alliance" />
                <XRef ID="124204003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thyroid dyshormonogenesis 2A</ElementValue>
                <XRef ID="MONDO:0010133" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TDH2A</ElementValue>
                <XRef Type="MIM" ID="274500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18189" />
                <XRef ID="18189" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="95716" DB="Orphanet" />
              <XRef ID="C1291299" DB="MedGen" />
              <XRef ID="MONDO:0010133" DB="MONDO" />
              <XRef Type="MIM" ID="274500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24421" SubmissionDate="2010-05-11" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606765.0001_THYROID DYSHORMONOGENESIS 2A" title="TPO, 4-BP INS, NT1227_THYROID DYSHORMONOGENESIS 2A" />
        <ClinVarAccession Accession="SCV000024421" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Abramowicz et al. (1992) demonstrated homozygosity for a 4-bp, frameshift-causing mutation in exon 8 of the TPO gene in an adopted boy with a partial iodide organification defect (TDH2A; 274500). The child presented with florid hypothyroidism at the age of 4 months; because of poor compliance with thyroxine treatment, he developed a large goiter with compressive symptoms requiring partial resection at the age of 12 years. The 4-bp insertion at position 1227 was due to duplication of a GGCC tetranucleotide.</Attribute>
              <Citation>
                <ID Source="PubMed">1401057</ID>
              </Citation>
              <XRef DB="OMIM" ID="274500" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bakker et al. (2000) found that a GGCC insertion in exon 8 at nucleotide 1277, leading to an early termination signal in exon 9, was the most frequently occurring mutation in 45 patients (35 families) with congenital hypothyroidism due to a total iodide organification defect (see 274500).</Attribute>
              <Citation>
                <ID Source="PubMed">11061528</ID>
              </Citation>
              <XRef DB="OMIM" ID="274500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <Name>TPO, 4-BP INS, NT1227</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, NT1227</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606765.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">THYROID DYSHORMONOGENESIS 2A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1381157" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="62322_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000708760" DateUpdated="2018-12-15" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GCCG" referenceAllele="-" start="1481222" stop="1481225" variantLength="4" />
            <GeneLocation>NM_000547.5:Ex8</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI920956" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=TPO</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790936" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1365390" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915859" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27373559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27617131</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23512414</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17468186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1401057</ID>
          </Citation>
          <Comment>The TPO c.1184_1187dupGCCG (p.Ala397ProfsTer76) variant is a frameshift variant that is predicted to cause premature truncation of the protein. The p.Ala397ProfsTer76 variant has been reported in at least five studies of individuals with congenital hypothyroidism and goiter, and is found in a total of 24 affected individuals from 17 families, including in a homozygous state in 13 individuals, in a compound heterozygous state in four individuals, and in a heterozygous state in seven individuals in whom a second variant was not identified (Abramowicz et al. 1992; Avbelj et al. 2007; Altmann et al. 2013; Cangul et al. 2015; Lof et al. 2016). The variant is also found in a heterozygous state in two unaffected individuals (Avbelj et al. 2007). Three families showed segregation of the variant with the disorder in a manner consistent with autosomal recessive inheritance (Avbelj et al. 2007; Cangul et al. 2015). The p.Ala397ProfsTer76 variant was absent from 50 controls but is reported at a frequency of 0.001576 in the European (Finnish) population of the Genome Aggregation Database. Based on the evidence and potential impact of frameshift variants, the p.Ala397ProfsTer76 variant is classified as pathogenic for congenital hypothyroidism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="ACGGC" referenceAllele="A" start="1481219" stop="1481219" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dupGCCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="274500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2670371" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000547.5:c.1184_1187dup|MedGen:C1291299" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001362032" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1401057</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27617131</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30240412</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15745925</ID>
          </Citation>
          <Comment>Variant summary: TPO c.1184_1187dupGCCG (p.Ala397ProfsX76) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay. The variant allele was found at a frequency of 0.0005268 in 151866 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in TPO causing Deficiency of iodide peroxidase (0.0005268 vs 0.0071). c.1184_1187dupGCCG has been reported in the literature in multiple individuals affected with congenital hypothyroidism and iodide organification defect (Makretskaya_2018, Cangul_2015, Rodrigues_2005, Abramowicz_1992). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated the variant to result in very low residual TPO activity (5% of a normal control) (Abramowicz_1992). Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Deficiency of iodide peroxidase</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1291299" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2697649" SubmissionDate="2020-11-24" DateLastUpdated="2020-12-12" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_000547.5:c.1184_1187dupGCCG|OMIM:274500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001369563" DateUpdated="2020-12-12" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2,PP4.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dupGCCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="274500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3784415" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-24" DateCreated="2021-09-24">
        <ClinVarSubmissionID localKey=":Chr.2_1481219_1481219_A_ACGGC|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001920535" DateUpdated="2021-09-24" DateCreated="2021-09-24" Type="SCV" Version="1" SubmitterName="Clinical Genetics, Academic Medical Center" OrgID="319965" OrganizationCategory="laboratory" OrgAbbreviation="KG-DNA AMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="ACGGC" referenceAllele="A" start="1481219" stop="1481219" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10399984</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3851884" SubmissionDate="2021-10-04" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.2_1481219_1481219_A_ACGGC|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001962830" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="ACGGC" referenceAllele="A" start="1481219" stop="1481219" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10419610</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4927016" SubmissionDate="2022-05-16" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="ANAL WES 59B|OMIM:274500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002515282" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Daryl Scott Lab, Baylor College of Medicine" OrgID="505993" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.6:c.1184_1187dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="274500" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">36474027</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11464682</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5022193" SubmissionDate="2022-07-12" DateLastUpdated="2022-09-03" DateCreated="2022-09-03">
        <ClinVarSubmissionID localKey="53614193|OMIM:274500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002568217" DateUpdated="2022-09-03" DateCreated="2022-09-03" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1 PM3_Strong PS3_Supportive</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="274500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11782039</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1133591" SubmissionDate="2022-04-13" DateLastUpdated="2023-03-04" DateCreated="2017-07-02">
        <ClinVarSubmissionID localKey="GDXSV:224488" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000581832" DateUpdated="2023-03-04" DateCreated="2017-07-02" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 17468186, 27617131, 27373559, 30240412, 29546359, 23512414, 15745925, 1401057, 11061528, 31430255, 31980526, 31589614, 32765423, 33726816)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:748471</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_100_20220413054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_57_20210930044205</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7171269" SubmissionDate="2023-03-09" DateLastUpdated="2023-03-18" DateCreated="2023-03-18">
        <ClinVarSubmissionID localKey="2-1481219-A-ACGGC" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003841596" DateUpdated="2023-03-18" DateCreated="2023-03-18" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1401057</ID>
          </Citation>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.053%). This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000429301 / PMID: 1401057). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001337" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000739" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000716" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000851" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001206744.2:c.1184_1187dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="274500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12919228</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966691" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="bbb6e18b28327dc6b38e956f4f746b990bad02cf231ddcd0566377f56467ad9c|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002022399" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5980934" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="3506097|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003292692" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11061528</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23236987</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25564141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15745925</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27373559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27617131</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29546359</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32765423</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala397Profs*76) in the TPO gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TPO are known to be pathogenic (PMID: 11061528, 23236987, 25564141). This variant is present in population databases (rs763941231, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with clinical features of thyroid dyshormonogenesis (PMID: 15745925, 27373559, 27617131, 29546359, 32765423). It has also been observed to segregate with disease in related individuals. This variant is also known as c.1182_1183insCGGC, 1183_1186dupGGCC. ClinVar contains an entry for this variant (Variation ID: 429301). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.1481219_1481220insCGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8840418" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3492737|TPO-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004758790" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The TPO c.1184_1187dupGCCG variant is predicted to result in a frameshift and premature protein termination (p.Ala397Profs*76). This variant (also known as 1273_1276dupGGCC) has been reported in multiple individuals with autosomal recessive congenital hypothyroidism (see for example, Abramowicz et al. 1992. PubMed ID: 1401057; Cangul et al. 2015. PubMed ID: 27617131; Table 1, Zou et al. 2018. PubMed ID: 29546359). This variant is reported in 0.16% of alleles in individuals of European (Finnish) descent in gnomAD. Frameshift variants in TPO are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000547.5:c.1184_1187dupGCCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TPO-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7719077" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="133943|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004138470" DateUpdated="2024-07-15" DateCreated="2023-11-20" Type="SCV" Version="7" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>TPO: PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TPO" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="ACGGC" referenceAllele="A" start="1481219" stop="1481219" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1381157" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5022193" TraitType="Disease" MappingType="XRef" MappingValue="274500" MappingRef="OMIM">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171269" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000739" MappingRef="HP">
        <MedGen CUI="C0003467" Name="Anxiety" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3966691" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1133591" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3784415" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171269" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24421" TraitType="Disease" MappingType="Name" MappingValue="THYROID DYSHORMONOGENESIS 2A" MappingRef="Preferred">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2697649" TraitType="Disease" MappingType="XRef" MappingValue="274500" MappingRef="OMIM">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171269" TraitType="Disease" MappingType="XRef" MappingValue="274500" MappingRef="OMIM">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171269" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000851" MappingRef="HP">
        <MedGen CUI="C0010308" Name="Congenital hypothyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171269" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001337" MappingRef="HP">
        <MedGen CUI="C0040822" Name="Tremor" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2670371" TraitType="Disease" MappingType="Name" MappingValue="Deficiency of iodide peroxidase" MappingRef="Preferred">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3851884" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7171269" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000716" MappingRef="HP">
        <MedGen CUI="C0011581" Name="Depression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8840418" TraitType="Disease" MappingType="Name" MappingValue="TPO-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="TPO-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790936" TraitType="Disease" MappingType="XRef" MappingValue="274500" MappingRef="OMIM">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5980934" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7719077" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4927016" TraitType="Disease" MappingType="XRef" MappingValue="274500" MappingRef="OMIM">
        <MedGen CUI="C1291299" Name="Deficiency of iodide peroxidase" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2020-11-19">SCV001369466</Accession>
        <Description>Updated the reporting strategy binding the interpretation to OMIM (instead of HPO)</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001528542</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

